Videoconferenced Yoga Interventions for Cancer Patients and their Caregivers during the COVID-19 Pandemic: A Report from a Clinician's Perspective.
Stella Snyder, Rosangela F Silva, Meagan S Whisenant...
https://pubmed.ncbi.nlm.nih.gov/34036820/Actively Recruiting
Led by M.D. Anderson Cancer Center · Updated on 2026-04-15
400
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating how a dyadic yoga program affects physical performance and quality of life in patients with stage I-IV non-small cell lung or esophageal cancer who are undergoing radiotherapy, along with their caregivers. This study aims to see if yoga can improve physical function, reduce fatigue, ease sleep difficulties, lower depressive symptoms, and enhance overall quality of life compared to an education program. The study also explores changes in symptom burden, inflammatory markers, cortisol rhythms, and dyadic symptom management skills. Participants are randomly assigned to one of two groups one group takes part in dyadic yoga sessions involving physical exercises and relaxation techniques lasting 60 minutes each, up to 15 sessions the other group receives dyadic education focused on managing symptoms for patients and caregivers, also lasting 60 minutes each for up to 15 sessions. After completing the intervention, participants are followed up every two weeks for three months, then monthly for up to six months. During the study, patient physical performance is measured with a 6-minute walk test at three months post-study. Quality of life assessments for both patients and caregivers continue for up to six months after the intervention. Researchers also collect data on symptom burden, inflammatory and cortisol markers, and participants experiences through questionnaires and ancillary studies. Safety monitoring and ongoing assessments help track the interventions effects over the follow-up period.
CONDITIONS
Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers
K
Kathrin Milbury
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Dyadic Yoga (Patient + Caregiver) | Dyadic Education (Patient + Caregiver) | Standard Supportive Care |
|---|---|---|---|
| What it is | Supervised yoga sessions designed for both patient and caregiver to participate together while undergoing radiotherapy. | Structured education and support program delivered to both patient and caregiver during radiotherapy. | Usual supportive care during radiotherapy without a structured dyadic yoga or education programme. |
| Role in the trial | Investigational intervention under study. | Active comparator arm providing educational support. | Represents typical care context not tested in this trial. |
| Primary purpose | To improve patient physical performance and quality of life, and to reduce caregiver distress. | To provide information and support to patient and caregiver during radiotherapy. | To offer routine symptom management and support without added structured dyadic intervention. |
| How it is delivered | Delivered as yoga sessions for both patient and caregiver during radiotherapy treatment period. | Delivered as education and support sessions to patient‑caregiver dyads during radiotherapy. | Occurs as part of usual oncology care without added structured dyadic sessions. |
| Evidence status | Randomized trial indicates improved 6‑minute walk test performance and reduced caregiver distress. | Serves as comparison in trial; no specific efficacy claims in report beyond serving as comparator. | Not specifically studied here; external evidence shows usual care lacks structured dyadic interventions but effect not measured directly. |
| Important risks | No safety concerns reported; yoga generally well tolerated in cancer supportive care contexts. | Education intervention carries minimal risk. | Standard supportive care involves routine clinical oversight with established safety. |
| Important limitations | Reported findings are early and from a relatively small sample; generalizability to broader populations may be limited. | Comparator lacks details on its structure and efficacy beyond serving as control. | Not formally studied in this trial; effectiveness relative to dyadic programmes is assumed, not measured. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 15 sessions
Participants undergo either dyadic yoga intervention sessions involving physical exercises and relaxation techniques or dyadic education program sessions focusing on symptom management strategies. Each session lasts 60 minutes for up to 15 sessions.
Up to 15 sessions, each lasting 60 minutes
Duration - Up to 6 months post-treatment
Participants and their caregivers are followed up every 2 weeks for 3 months and then every month for up to 6 months after completing the treatment sessions.
Biweekly visits for 3 months, then monthly visits for up to 6 months
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Stella Snyder, Rosangela F Silva, Meagan S Whisenant...
https://pubmed.ncbi.nlm.nih.gov/34036820/M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborating Sponsor